Loading viewer...
investor_presentation
Format: PDF investor_presentation
Oncolytics Biotech presented its investor overview in August 2023, detailing pelareorep, an intravenously-delivered immunotherapy designed to enhance tumor susceptibility to oncology treatments. The presentation outlines the company's development strategy, clinical milestones, market opportunities, and anticipated catalysts in breast and pancreatic cancer applications.
Oncolytics Biotech 2021 Cancer Research Presentation
investor_presentationinvestor_presentation
48 Pages
investor_presentation
39 Pages
Veeco Instruments Inc.
investor_presentation
Coles Group